G1 Therapeutics to Participate in Four Investor Conferences in September 2020

    NEXT STORY
    Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences
    PREV STORY
    Iterum Therapeutics Announces Revised Results of Rights Offering
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) during the 62nd ASH Annual Meeting

    author_avatar
    NASDAQ Market News

    Teleflex Announces Quarterly Dividend

    author_avatar
    NASDAQ Market News

    Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)

    author_avatar
    NASDAQ Market News